Uterine fibroids are non-cancerous growths in the uterus that can cause heavy menstrual bleeding, pelvic pain, and infertility. Fibroids are common in women of childbearing age, and they are believed to be caused by a combination of genetic and environmental factors. Fibroids are most often found during a pelvic exam, but they can also be detected through imaging tests such as an ultrasound or MRI. Fibroids can range in size from a few millimeters to several centimeters in diameter. They can be located inside the uterus, on the outside of the uterus, or within the uterine walls. Some fibroids are asymptomatic, while others can cause symptoms such as heavy menstrual bleeding, pelvic pain, frequent urination, and constipation. In some cases, fibroids can cause infertility or miscarriage. Treatment of uterine fibroids depends on the severity of symptoms and the size of the fibroids. Treatments range from medications to hormone therapy to surgery. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) can be used to reduce pain and other symptoms of uterine fibroids. Hormone therapy is used to slow the growth of fibroids, while surgery is an option for larger fibroids or those that cause severe symptoms. Uterine fibroids are common in women of reproductive age, and they can cause a variety of symptoms. Treatment options vary depending on the size and location of the fibroids, and the severity of symptoms. It is important to speak to a healthcare professional to discuss the best treatment option for each individual.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia